Pulmonary mycoses treated by topical amphotericin B

Pulmonary mycoses treated by topical amphotericin B

Since its discovery, amphotericin B (AmB) became a key management because it is the most common antifungal drug with activity to disrupt the fungal cell wall. Furthermore, it is the first-choice treatment in pulmonary mycoses that may consider lethal infection; the difference in lipid structure betw...

Full description

Bibliographic Details
Main Author: Falah Hasan Obayes AL-Khikani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
antifungal agents
fungal treatment
pulmonary mycosis
topical amphotericin b
topical treatment
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2020;volume=4;issue=2;spage=123;epage=126;aulast=AL-Khikani

Internet

http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2020;volume=4;issue=2;spage=123;epage=126;aulast=AL-Khikani

Similar Items